OMCL 241220 25.00P (OMCL241220P25000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

OMCL241220P25000

Watchlist

0.08
+0.03+60.00%

15min DelayClose Nov 29 13:00 ET

0.08High0.08Low

Intraday

5D
Daily

News

Why Is Omnicell (OMCL) Down 0.4% Since Last Earnings Report?
Yahoo FinanceNov 29 11:31 ET
Should You Investigate Omnicell, Inc. (NASDAQ:OMCL) At US$48.46?
Yahoo FinanceNov 29 08:57 ET
Calculating The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)
Simply Wall StNov 27 05:24 ET
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference
BusinesswireNov 22 16:01 ET
Colliers Securities Initiates Omnicell(OMCL.US) With Buy Rating, Announces Target Price $52
Moomoo NewsNov 21 17:31 ET · Ratings
Beyond The Numbers: 6 Analysts Discuss Omnicell Stock
BenzingaNov 21 11:00 ET

Comments

Moomoo AI

Feb 23 05:55

Omnicell stock is undervalued, presenting a buying opportunity. The company's future outlook is optimistic with robust cash flows expected to increase share value. However, consider other factors like financial health before investing.

Is Now The Time To Look At Buying Omnicell, Inc. (NASDAQ:OMCL)?

Moomoo AI

Feb 5 08:15

The company's debt situation and EBIT loss of US$31m over the last twelve months raise concerns about its financial health. The balance sheet is considered far from match-fit and the stock is deemed very risky.

Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?

Moomoo AI

Dec 25, 2023 05:09

Omnicell's low P/S ratio suggests limited growth. Lackluster future revenue forecasts damages its value. Investors await improved performance as current weak outlook pressures stock price.

Omnicell, Inc.'s (NASDAQ:OMCL) Share Price Is Matching Sentiment Around Its Revenues

Moomoo AI

Dec 6, 2023 05:40

Given the falling EPS and poor performance over the last three years, future earnings performance is being considered critical for shareholders. Potential investors are cautioned to ensure they are investing in a high-quality business amid challenges.

Shareholders in Omnicell (NASDAQ:OMCL) Have Lost 70%, as Stock Drops 3.2% This Past Week